DAWN Live signaler | Maksimer profitt med Getagraph.com

KJøP 107377 min ago

@ $14.66

Utstedt: 14 feb 2024 @ 21:53

Avkastning: 1.77%

Forrige signal: feb 14 - 15:31

Forrige signal: Selg

Avkastning: 1.24 %

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers...

Stats
Dagens volum	3.60M
Gjennomsnittsvolum	966 801
Markedsverdi	1.30B
EPS	$0 ( 2024-03-04 )
Neste inntjeningsdato	( $-0.670 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.30
ATR14	$0.0500 (0.34%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Blackman Samuel C.	Sell	10 000	Common Stock
2024-03-25	Blackman Samuel C.	Sell	10 000	Common Stock
2024-03-11	Blackman Samuel C.	Sell	30 000	Common Stock
2024-02-27	Blackman Samuel C.	Sell	20 000	Common Stock
2024-02-15	Dubow Adam	Sell	3 687	Restricted Stock Unit (RSU)

INSIDER POWER
46.99
Last 98 transactions
Buy: 3 591 581 \| Sell: 1 422 797

Volum Korrelasjon

Lang: 0.18 (neutral)

Kort: -0.80 (moderate negative)

Signal:(47.978) Neutral

Day One Korrelasjon

10 Mest positive korrelasjoner
CASA	0.96
ESPR	0.953
ALT	0.952
KZR	0.952
SONN	0.95
ACER	0.949
MRBK	0.949
AHPI	0.948
IOBT	0.944
PFSW	0.943

10 Mest negative korrelasjoner
STAY	-0.966
DSPG	-0.963
DVCR	-0.947
LMNX	-0.947
OPNT	-0.942
RAM	-0.94
NTUS	-0.935
AMYT	-0.935
COCO	-0.928
CPTA	-0.928

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Day One Korrelasjon - Valuta/Råvare

0.30
( neutral )

-0.05
( neutral )

0.00
( neutral )

-0.44
( neutral )

0.21
( neutral )

0.01
( neutral )

Day One Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-383 000 (0.00 %)
EPS:	$-2.37

FY	2023
Omsetning:	$0
Bruttogevinst:	$-383 000 (0.00 %)
EPS:	$-2.37

FY	2022
Omsetning:	$0
Bruttogevinst:	$-531 000 (0.00 %)
EPS:	$-2.02

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-4.62

Financial Reports:

No articles found.

Day One

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.